Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency
Beteiligte Einrichtungen
Bibliografische Daten
Originalsprache | Englisch |
---|---|
ISSN | 0271-9142 |
DOIs | |
Status | Veröffentlicht - 04.2022 |
PubMed | 35174440 |
---|